Skip to main navigation Skip to search Skip to main content

Apixaban overdose in children: case report and proposed management. A brief communication from the Pediatric and Neonatal Thrombosis and Hemostasis SSC of ISTH

  • Meredith Wiggins*
  • , Tina Biss
  • , Leslie Raffini
  • , Heleen Van Ommen
  • , Anthony Chan
  • , Christina Vanderpluym
  • , Neil Goldenberg
  • , Paul Monagle
  • *Corresponding author for this work
  • Sydney Children's Hospital
  • University of New South Wales
  • Newcastle upon Tyne Hospitals NHS Foundation Trust
  • Children's Hospital of Philadelphia
  • McMaster University
  • Hebrew SeniorLife
  • Johns Hopkins University

Research output: Contribution to journalArticleAcademicpeer-review

3 Citations (Scopus)
36 Downloads (Pure)

Abstract

Background: Direct oral anticoagulants are commonly prescribed for adults and increasingly also for children requiring anticoagulation therapy. While household medications should not be accessible to children, accidental, and intentional overdoses occur. Key Clinical Question: How should apixaban overdose in children be managed?. Clinical Approach: We present a case of an accidental overdose with the factor Xa antagonist apixaban in a young child and propose an approach to the management of cases of apixaban overdose in children. Conclusion: Given the increasing use of direct oral anticoagulants, it is important to have an approach to the management of overdose of these medications.

Original languageEnglish
Article number102312
JournalResearch and Practice in Thrombosis and Haemostasis
Volume8
Issue number1
DOIs
Publication statusPublished - Jan 2024

Bibliographical note

Publisher Copyright: © 2024 The Authors

Fingerprint

Dive into the research topics of 'Apixaban overdose in children: case report and proposed management. A brief communication from the Pediatric and Neonatal Thrombosis and Hemostasis SSC of ISTH'. Together they form a unique fingerprint.

Cite this